Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker

Background: Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are lacking. Materials & methods: We analyzed data...

詳細記述

書誌詳細

出版年:	Future Science OA
主要な著者:	Sérgio Machado Lopes, Susana Roncon, Ana Catarina Pinho, Filipa Bordalo, Luís Antunes, Fernando Campilho, António Campos, Altamiro Costa-Pereira
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2020-09-01
主題:	ECP extracorporeal photopheresis GvHD immunotherapy Treg
オンライン･アクセス:	https://www.future-science.com/doi/10.2144/fsoa-2020-0107